We are the world’s largest oncology focused imaging CRO (iCRO); we specialize in developing and deploying optimal imaging in early to late-stage clinical trials and supporting regulatory submissions. We have staff strategically located in Europe and Asia to serve over 40 countries with offices in India, the Netherlands, Switzerland and new offices in China and London.